Reports for BAYER INC
Company Name
BAYER INC
Totals |
||
Shortage reports |
85 |
|
| Actual shortage: | 8 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (12%) | |
| Resolved: | 67 (79%) | |
Discontinuation Reports |
23 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 22 (96%) | |
| Reversed: | 1 (4%) | |
Late reports |
6 (6%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ULTRAVIST 300 | 62% | SOLUTION | Actual shortage | 2024-04-02 | 2024-04-02 | 224127 |
| ULTRAVIST 370 | 77% | SOLUTION | Actual shortage | 2024-01-12 | 2024-04-02 | 215779 |
| CLIMARA 50 | 50MCG | PATCH | Actual shortage | 2024-04-17 | 2024-04-26 | 225331 |
| CLIMARA 25 | 25MCG | PATCH | Actual shortage | 2024-01-17 | 2024-04-26 | 216236 |
| XARELTO | 10MG | TABLET | Actual shortage | 2024-04-25 | 2024-05-04 | 226202 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GLUCOBAY | 100MG | TABLET | Discontinued | 2023-07-11 | 2023-07-11 | 198128 |
| GLUCOBAY | 50MG | TABLET | Discontinued | 2023-07-11 | 2023-07-11 | 198131 |
| STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-07-14 | 2023-07-14 | 198701 |